Avalo Therapeutics, Inc.

AVTX·NASDAQ·$16.02Share Price as of 11/2·$181MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/06/26 10-QQ1 ended 03/31/2605/13/26 10-KFY 202503/23/26 10-QQ3 ended 09/30/2511/06/25 10-QQ2 ended 06/30/2508/07/25

Disclosures

8-KCurrent report08/06/26 8-KCurrent report06/23/26 8-KCurrent report06/16/26 8-KCurrent report06/12/26 8-KCurrent report06/08/26

Prospectuses and Registrations

424B3Prospectus07/28/26 S-3Shelf registration07/17/26 424B5Prospectus supplement05/07/26 424B5Prospectus supplement05/05/26 S-8Registration of securities for employees03/23/26

Proxies

DEF 14ADefinitive proxy04/10/26 DEFA14AAdditional proxy materials04/10/26 DEF 14ADefinitive proxy05/01/25 DEFA14AAdditional proxy materials05/01/25 DEF 14ADefinitive proxy06/27/24

Ownership

SC 13GBeneficial ownership10/29/26 Form 4Insider transaction10/02/26 Form 4Insider transaction10/02/26 Form 4Insider transaction10/02/26 Form 4Insider transaction09/18/26

Other

EFFECTRequest for effectiveness07/28/26 ARSAnnual report to shareholders04/10/26 EFFECTRequest for effectiveness01/20/26 CORRESPCorrespondence with the SEC01/15/26 UPLOADLetter from the SEC01/14/26